Disclaimer: I am not saying that the following will definitely happen because it is based on assumptions that may not eventuate. But it is "food for thought" and should generate a lot of "vigorous" if not "heated" discussion.
Hypothesis: Correction could complete at approx $9.00 towards the end of the year (Nov - Dec 2017)
Assumptions:
1. Stock continues to follow long term parabolic uptrend (green up sloping line on attached chart).
2. Stock continues to correct at the current rate of descent.
Calculation:
Correction could end where downtrend line connecting swing point lows (blue line sloping downwards) intersects green parabolic uptrend line.
Note: The price projection matches fairly close to the price levels of the three swing point highs in 2007, 2009 & 2013 which would be a logical level of support.
Whether such a wonderful company as PMV could fall to $9.00 is probably unlikely but stranger things have happened in the stock market.
Monthly Bar Chart
![]()
PMV
premier investments limited
Add to My Watchlist
1.29%
!
$22.70

Chart - where & when will the correction end?
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$22.70 |
Change
0.290(1.29%) |
Mkt cap ! $3.629B |
Open | High | Low | Value | Volume |
$22.62 | $22.92 | $22.51 | $21.70M | 957.4K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 7592 | $22.66 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$22.70 | 40418 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 2800 | 22.500 |
1 | 750 | 22.400 |
1 | 675 | 22.250 |
2 | 4704 | 22.200 |
1 | 225 | 22.100 |
Price($) | Vol. | No. |
---|---|---|
22.850 | 755 | 2 |
22.900 | 1008 | 2 |
23.030 | 157 | 1 |
23.330 | 714 | 1 |
23.500 | 28 | 1 |
Last trade - 16.19pm 21/08/2025 (20 minute delay) ? |
Featured News
PMV (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Michael Thurn, MD & CEO
Michael Thurn
MD & CEO
SPONSORED BY The Market Online